Published in J Rheumatol on January 01, 1991
Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis (1994) 0.87
The use of low-dose etanercept as an alternative therapy for treatment of ankylosing spondylitis: a case series. Rheumatol Int (2011) 0.83
Risks of relapse in patients with acute anterior uveitis. Br J Ophthalmol (2006) 0.80
Echocardiographic abnormalities in ankylosing spondylitis. Ann Rheum Dis (1992) 0.80
Matching prevalence of peripheral arthritis and acute anterior uveitis in individuals with ankylosing spondylitis. Ann Rheum Dis (1995) 0.78
The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum (1991) 11.66
A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol (1994) 11.17
Striking prevalence of ankylosing spondylitis in "healthy" w27 positive males and females. N Engl J Med (1975) 4.25
Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum (1997) 4.14
Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol (1994) 4.00
Clinical history as a screening test for ankylosing spondylitis. JAMA (1977) 3.60
Sex ratio in the spondyloarthropathies and its relationship to phenotypic expression, mode of inheritance and age at onset. J Rheumatol (1993) 3.39
Ankylosing spondylitis--an analytical review of 1500 patients: the changing pattern of disease. J Rheumatol (1988) 3.29
Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. J Rheumatol (1999) 2.12
Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J Rheumatol (1997) 2.11
Bone loss as well as bone formation is a feature of progressive ankylosing spondylitis. Br J Rheumatol (1990) 2.03
Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum (1981) 1.97
The hand radiograph as a diagnostic discriminant between seropositive and seronegative 'rheumatoid arthritis': a controlled study. Ann Rheum Dis (1983) 1.96
Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis (2000) 1.92
Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet (2001) 1.82
Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol (2001) 1.82
The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum (1998) 1.80
HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis (1996) 1.79
An "experimental" epidemic of Reiter's syndrome revisited. Follow-up evidence on genetic and environmental factors. Ann Intern Med (1976) 1.74
The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol (1996) 1.73
Total hip arthroplasty in ankylosing spondylitis: outcome in 340 patients. J Rheumatol (2001) 1.71
Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N Engl J Med (1981) 1.69
Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Arthritis Rheum (2001) 1.68
Destructive arthritis, rheumatoid factor, and HLA-DR4. Susceptibility versus severity, a case-control study. Arthritis Rheum (1989) 1.62
The chronicity of symptoms and disability in Reiter's syndrome. An analysis of 131 consecutive patients. Ann Intern Med (1979) 1.53
A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI) J Rheumatol (1995) 1.49
A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum (1998) 1.41
The natural history of ankylosing spondylitis: is the disease really changing? J Rheumatol (1989) 1.40
Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet (1990) 1.39
Increasing age at presentation for patients with ankylosing spondylitis. Ann Rheum Dis (1992) 1.39
Atypical antineutrophil cytoplasmic antibodies in patients with ankylosing spondylitis. Br J Rheumatol (1995) 1.38
Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. J Rheumatol (1999) 1.28
Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial. Rheumatology (Oxford) (1999) 1.28
Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls. Arthritis Rheum (1983) 1.25
HLA-B27: to type of not to type? Ann Intern Med (1980) 1.23
Reiter's syndrome following epidemic shigellosis. J Rheumatol (1982) 1.23
Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol (1983) 1.23
Selective IgA deficiency and spondyloarthropathy: a distinct disease? Ann Rheum Dis (1990) 1.20
Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men. J Rheumatol (1990) 1.20
The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade). Rheumatology (Oxford) (2004) 1.17
Ankylosing spondylitis in women and men: a case-control study. J Rheumatol (1983) 1.15
The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum (1998) 1.14
Search for Reiter's syndrome after an outbreak of Shigella sonnei dysentery. J Rheumatol (1980) 1.13
Is disease severity in ankylosing spondylitis genetically determined? Arthritis Rheum (2001) 1.10
Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group. Ann Rheum Dis (2003) 1.08
Non-B27 MHC associations of ankylosing spondylitis. Genes Immun (2006) 1.06
Ankylosing spondylitis: the correlation between a new metrology score and radiology. Br J Rheumatol (1995) 1.06
Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis. Hum Mol Genet (2000) 1.05
Socioeconomic status in ankylosing spondylitis: relationship between occupation and disease activity. J Rheumatol (1997) 1.04
The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the bath ankylosing spondylitis radiology hip index. J Rheumatol (2000) 1.01
An update on the Bath Ankylosing Spondylitis Disease Activity and Functional Indices (BASDAI, BASFI): excellent Cronbach's alpha scores. J Rheumatol (1996) 0.99
The epidemiology of spondylodiscitis in ankylosing spondylitis--a controlled study. Br J Rheumatol (1996) 0.99
Double-bind cross-over tiral of flurbiprofen and phenylbutazone in ankylosing spondylitis. Br Med J (1974) 0.99
Ankylosing spondylitis. Clin Rheum Dis (1985) 0.99
The prevalence and nature of back pain in an industrial complex: a questionnaire and radiographic and HLA analysis. Spine (Phila Pa 1976) (1980) 0.99
Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. J Rheumatol (1996) 0.97
Letter: "Ankylosing rheumatoid arthritis", ankylosing spondylitis, and HL-A antigens. Lancet (1974) 0.97
Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors. J Rheumatol (2001) 0.97
The natural history of ankylosing spondylitis. Does it burn out? J Rheumatol (1993) 0.97
Willingness to accept risk in the treatment of rheumatic disease. J Epidemiol Community Health (1990) 0.96
Aortitis in ankylosing spondylitis: early detection of aortic root abnormalities with two dimensional echocardiography. Am J Cardiol (1982) 0.94
Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized trial. Ann Intern Med (1985) 0.94
Ankylosing spondylitis sine sacroiliitis. Arthritis Rheum (1979) 0.93
Presence of circulation immune complexes in Reiter's syndrome and ankylosing spondylitis. Clin Immunol Immunopathol (1981) 0.93
Bath Ankylosing Spondylitis Functional Index. Br J Rheumatol (1995) 0.92
Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis. Ann Rheum Dis (1994) 0.92
The X-chromosome and susceptibility to ankylosing spondylitis. Arthritis Rheum (2000) 0.92
Exercise in ankylosing spondylitis: how much is optimum? J Rheumatol (1998) 0.91
The case against seronegative rheumatoid arthritis. Am J Med (1981) 0.91
Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol (1999) 0.91
Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis. Arthritis Rheum (1998) 0.90
Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Bull Rheum Dis (1982) 0.90
Late onset ankylosing spondylitis--a distinct disorder? Br J Rheumatol (1991) 0.88
Perception of prescription drug risks: a survey of patients with ankylosing spondylitis. J Rheumatol (1990) 0.88
The close correlation between symptoms and disease expression in HLA B27 positive individuals. J Rheumatol (1977) 0.88
A prospective nationwide cross-sectional study of NSAID usage in 1331 patients with ankylosing spondylitis. J Rheumatol (1990) 0.87
The changing epidemiology of rheumatic diseases: should ankylosing spondylitis now be included? Br J Rheumatol (1990) 0.87
Sustained improvement of intractable rheumatoid arthritis after total lymphoid irradiation. Arthritis Rheum (1983) 0.87
Reactive arthritis. Br Med J (1980) 0.87
Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis (1994) 0.87
Reiter's syndrome. Med Clin North Am (1977) 0.86
Workshop III. Management of Reiter's syndrome. Ann Rheum Dis (1979) 0.86
The relationship between pelvic, spinal and hip involvement in ankylosing spondylitis--one disease process or several? Br J Rheumatol (1988) 0.86
A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis. Arthritis Rheum (1989) 0.86
Raised serum creatine phosphokinase activity in ankylosing spondylitis. Ann Rheum Dis (1975) 0.86
Low dose amitriptyline in ankylosing spondylitis: a short term, double blind, placebo controlled study. J Rheumatol (1997) 0.86
The effect of transforming growth factor beta1 gene polymorphisms in ankylosing spondylitis. Rheumatology (Oxford) (2003) 0.85
A case-control study of juvenile- and adult-onset ankylosing spondylitis. J Rheumatol (1983) 0.84
Ankylosing spondylitis and epidemic Reiter's syndrome: genetics and environment [Proceedings]. Ann Rheum Dis (1976) 0.83
Rarity of nephropathy in ankylosing spondylitis. Arthritis Rheum (1982) 0.83
Porphyria cutanea tarda associated with methotrexate therapy. Br J Rheumatol (1993) 0.83
Bronchorrhoea. Br Med J (1972) 0.83
Bacterial endocarditis presenting as acute monoarthritis. Ann Rheum Dis (1988) 0.83
Juvenile onset ankylosing spondylitis--more girls than we thought? J Rheumatol (1997) 0.83
Primary ankylosing spondylitis, psoriatic and enteropathic spondyloarthropathy: a controlled analysis. J Rheumatol (1991) 0.83